已收盘 04-02 16:00:00 美东时间
+0.140
+2.54%
今日重点评级关注:Canaccord Genuity:维持Generac控股"买入"评级,目标价从275美元升至300美元;Oppenheimer:维持Biogen"跑赢大市"评级,目标价从250美元升至275美元
04-02 16:17
今日重点评级关注:Maxim Group:上调Theriva Biologics评级至"买入",目标价1美元;HC Wainwright & Co.:维持Bicara Therapeutics"买入"评级,目标价从40美元升至42美元
04-01 16:34
Morgan Stanley analyst Ronald Kamdem maintains Hudson Pacific Properties (NYSE:HPP) with a Underweight and lowers the price target from $8 to $5.
04-01 00:51
今日重点评级关注:HC Wainwright & Co.:维持Helus Pharma"买入"评级,目标价从55美元升至95美元;HC Wainwright & Co.:维持Compass Pathways"买入"评级,目标价从40美元升至70美元
03-03 20:22
Hudson Pacific Properties shares are trading higher after the company reported ...
02-26 23:07
Hudson Pacific Properties (NYSE:HPP) reported its Q4 earnings results on Thursd...
02-26 22:10
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
今日重点评级关注:杰富瑞:上调BioAge Labs评级至"买入",目标价从9美元升至62美元;RBC Capital:维持COMPASS Pathways Plc Sponsored ADR"跑赢大市"评级,目标价从21美元升至22美元
02-19 16:21
Shares of real estate-related stocks are trading lower amid concerns that AI ap...
02-13 00:20
今日重点评级关注:Piper Sandler:上调Korro Bio评级至"超配",目标价从11美元升至30美元;Piper Sandler:维持Nurix Therapeutics"超配"评级,目标价从32美元升至35美元
01-30 17:38